Drugs and Devices

FDA restricts patient access to rosiglitazone

The U.S. Food and Drug Administration (FDA) has added new restrictions on how rosiglitazone-containing medicines (Avandia, Avandamet, Avandaryl): Healthcare providers must enroll in a special program in order to prescribe the medicines, and patients must enroll in the same program in order to obtain their medicines through the mail. After November 18, 2011, rosiglitazone-containing medicines will no longer be available through retail pharmacies. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares